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Abstract
Glucocorticoids (GCs) have a profound effect on adipose
biology increasing tissue mass causing central obesity. The pre-
receptor regulation of GCs by 11b-hydroxysteroid dehydro-
genasetype1(11b-HSD1)thatactivatescortisolfromcortisone
hasbeenpostulatedasafundamentalmechanismunderlyingthe
metabolic syndrome mediating adipocyte hyperplasia and
hypertrophy in the omental (OM) depot.Orbital adipose tissue
(OF)isthesiteofintenseinﬂammationandtissueremodellingin
several orbital inﬂammatory disease states. In this study, we
describe features of the GC metabolic pathways in normal
human OF depot and compare it with subcutaneous (SC) and
OM depots. Using an automated histological characterisation
technique,OFadipocyteswerefoundtobesigniﬁcantlysmaller
(parameters:area,maximumdiameterandperimeter)thanOM
and SC adipocytes (P!0.001). Although immunohistochem-
ical analyses demonstrated resident CD68
C cells in all three
whole tissue adipose depots, OF CD68 mRNA and protein
expression exceeded that of OM and SC (mRNA, P!0.05;
protein, P!0.001). In addition, there was higher expression of
glucocorticoidreceptor (GR)a mRNA inthe OF whole tissue
depot (P!0.05). Conversely, 11b-HSD1 mRNA together
with the markers of late adipocyte differentiation (FABP4 and
G3PDH)weresigniﬁcantlylowerinOF.PrimaryculturesofOF
preadipocytes demonstrated predominant 11b-HSD1 oxo-
reductase activity with minimal dehydrogenase activity. Orbital
adipocytes are smaller, less differentiated, and express low levels
of11b-HSD1butabundantGRacomparedwithSCandOM.
OF harbours a large CD68
C population. These characteristics
deﬁne an orbital microenvironment that has the potential to
respond to sight-threatening orbital inﬂammatory disease.
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Introduction
Adipose tissue is a highlyactive endocrine organ regulatednot
only by a range of external factors, such as the autonomic
nervous system and circulating hormones, but also has the
ability to modulate its own metabolic activity. One important
group of regulating factors are the adrenocorticosteroids. Of
these, glucocorticoids (GCs) have a profound effect on
adipose biology increasing tissue mass giving rise to obesity in
conditions such as Cushing’s disease or following the use of
exogenous glucocorticoids. Their role in simple obesity is,
however, controversial. Regulation of adipose tissue mass
involves integration of a variety of complex mechanisms,
including the enzyme 11b-hydroxysteroid dehydrogenase
type 1 (11b-HSD1). 11b-HSD1 is an NADPH-dependent
short-chain alcohol dehydrogenase, localised in the lumen of
the endoplasmic reticulum, that interconverts active and
inactive GCs (Tomlinson et al. 2004). Although it has
bidirectional capacity, in vivo it functions as an oxo-reductase
activating cortisol from cortisone due to the provision of a
cofactor, NADPH, by a second regulatory enzyme, hexose-
6-phosphate dehydrogenase (H6PDH), thereby mediating
glucocorticoid receptor (GR) responses (Draper et al. 2003,
Bujalska et al. 2005). 11b-HSD1 is involved in a number of
disease processes, including insulin resistance (Kotelevtsev
et al. 1997), osteoporosis (Cooper et al. 2000, Tomlinson et al.
2000), glaucoma (Rauz et al. 2003), ocular surface renewal
(Onyimba et al. 2006), inﬂammation (Thieringer et al. 2001,
Zhang et al. 2005) and the metabolic syndrome – a cluster of
cardiovascular risk factors, including hypertension, obesity,
hyperlipidaemia and insulin resistance (Masuzaki et al. 2003).
11b-HSD1 is highly expressed in human omental (OM)
and subcutaneous (SC) tissue, although expression and
activity are higher in OM preadipocytes, the ﬁbroblast-like
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adipose tissue (Bujalska et al. 1997, 1999). The enzyme is
induced upon adipocyte differentiation in human adipose
tissue cultures (preadipocytes to adipocytes) and is thought to
be related to a ‘switch’ in enzyme set point from
dehydrogenase (preadipocytes) to oxo-reductase (adipocytes)
without any signiﬁcant change in 11b-HSD1 mRNA levels
(Bujalska et al. 2002). This observation is explained by the
induction of H6PDH across differentiation (Bujalska et al.
2005). With the known effect of glucocorticoids on adipose
tissue function and distribution, it has been postulated that the
enhanced conversion of cortisone to cortisol within omental
adipose tissue plays an important role in the pathogenesis of
central obesity (Bujalska et al. 2002, Tomlinson et al. 2002).
Cortisol generation after exogenous introduction of
cortisone, however, is reduced with increasing body mass
index (BMI), and a reduction in activity and expression of
11b-HSD1 in OM preadipocytes derived from samples taken
from obese volunteers, is seen. These data suggest that hepatic
11b-HSD1 protects against the metabolic effects of simple
obesity (Tomlinson et al. 2004). Nevertheless, central obesity
is a characteristic feature of mice overexpressing 11b-HSD1
within adipocytes (Masuzaki et al. 2001). The mechanisms
underlying obesity are complex, but recent ﬁndings suggest a
further role for chronic inﬂammation that may activate
adipose tissue. Increased accumulation of CD68
C macro-
phages is seen in SC adipose depots in patients with high BMI
and obese phenotypes, and increased expression of monocyte
chemoattractant protein (MCP)-1, macrophage inﬂam-
matory protein (MIP)-1a and MAC-1 is evident in rodent
white adipose tissue after diet-induced obesity (Weisberg et al.
2003, Wellen & Hotamisligil 2003, Xu et al. 2003).
Orbital fat (OF) represents a highly specialised adipose
tissue depot that occupies the space behind the eyeball
(known as the orbit). OF ﬁlls most of the orbital cavity, and
surrounds the globe, extraocular muscles, nerves and vessels
providing support to these delicate structures and protecting
against sight-threatening mechanical and inﬂammatory
trauma (Wolfram-Gabel & Kahn 2002). Two types of orbital
adipose tissue have been deﬁned: anterior OF consisting
chieﬂy of small adipocytes that are separated by thick
conjunctival septa providing support to intraorbital structures,
and posterior OF consisting of larger adipocytes separated by
thin conjunctival septa enabling structural movements within
the orbit (Bremond-Gignac et al. 2004). Over 60% of orbital
disorders are inﬂammatory in origin (Rootman 2002). OF is
the site for intense inﬂammation in several disease states of the
orbit including local conditions, such as orbital cellulitis,
orbital myositis, idiopathic orbital inﬂammatory disease, as
well as systemic metabolic disorders (thyroid-associated
ophthalmopathy) and generalised vasculitides (Wegener’s
granulomatosis). Orbital ﬁbroblasts and other resident orbital
cells (macrophages and dendritic cells) are known to
participate in the initiation and perpetuation of many of
these disease processes secreting mediators that are crucial to
orchestrating orbital immune and inﬂammatory responses and
tissue matrix remodelling (Burnstine et al. 1998, Heufelder
2000). OF, like SC and OM depots, expresses GR (Heufelder
et al. 1992, Burnstine et al. 1998, Muhlberg et al. 2000).
Exogenous GCs are known to modulate the autocrine and
paracrine interactions between OF and resident or inﬁltrating
inﬂammatory cells (lymphocytes and macrophages), leading
to the secretion of chemokines and cytokines (Burnstine et al.
1998, Valyasevi et al. 2001, Kumar & Bahn 2003, Chen et al.
2005), mediating OF proliferation (Heufelder & Bahn 1994)
and production of matrix proteins (Kaback & Smith 1999,
Han & Smith 2005). To date, no studies have characterised
the role of 11b-HSD1 and the pre-receptor regulation of
endogenous glucocorticoids in OF. In this study, we describe
features of the GC metabolic pathways in normal human OF
depot and compare it with SC and OM depots.
Materials and Methods
Collection of human adipose tissue
PairedOMandSCfatwasobtainedfrom50non-obese(BMI!
25 kg/m
2) patients undergoing elective abdominal surgery for
non-malignant conditions. Surgically acquired normal orbital
adiposetissue specimens(avoiding the anteriorand nasal orbital
adipose tissue) were obtained from 40 non-obese (BMI!
25 kg/m
2) patients undergoing orbital or eyelid reconstructive
procedures carried out at a regional tertiary referral centre
(Birmingham and Midland Eye Centre, Birmingham, UK).
Patients with orbital tumours, those on exogenous corticoster-
oids, or with underlyingendocrine disease were excluded from
the study. Each fat specimen was ﬁxed in formalin, stored in
RNAlater at K20 8C for RNA extraction or placed in a sterile
universal container for immediate processing where sufﬁcient
starting tissue was available.
Characterisation of whole tissue adipocyte morphology
Formalin ﬁxed parafﬁn embedded 5 mm sections of OF
(nZ17), SC (nZ8) and OM tissue (nZ8) were stained with
haematoxylin and eosin and photographed in triplicate using
an Olympus-BH-2-RFC microscope (Olympus UK Ltd,
Southall, Middx, UK) and MicroFireTM-S99808 camera
(Indigo Scientiﬁc, Baldock, Herts, UK). The images were
processed using the green channel to enhance edge
prominence using Image-Pro Plus (v4.0, Media Cybernetics,
Silver Spring, MD, USA). Software parameters were
optimised in order to identify the visual edge of the cell
membrane and generate an outline of the cell proﬁles for
analysis. The scaling factor was calculated by photographing a
micro-grid counting area of 500!584 mmc a p t u r i n ga
minimum of 100 cells (the exact number varying according
to the size of the adipocytes). Images were taken in triplicate
for each specimen, i.e. approximately 300 adipocytes were
evaluated for each histological section examined. The
following descriptive variables were measured: cell diameter,
I J BUJALSKA and others . 11b-HSD1 and orbital fat 280
Journal of Endocrinology (2007) 192, 279–288 www.endocrinology-journals.orglength of longest line joining two points and passing through
centroid; roundness, ((perimeter)2/4parea); radius ratio,
largest radius/smallest radius; feret length, calliper longest
length; cell area (mm
2); heterogeneity, fraction of pixels that
deviate more than 10% from average intensity and margina-
tion, relative distribution of object intensity between centre
and margin (larger value represents brighter centre and 0.33
represents homogeneity).
Immunohistochemistry
Immunohistochemical analyses were performed on 5 mm
sections OF, SC and OM tissues mounted on charged slides.
CD68 immunohistochemistry Dewaxed and rehy-
drated slides of OF, SC and OM sections were blocked
with hydrogen peroxide for 15 min before antigen
retrieval using Tris/EDTA tris-buffered saline (TBS)
buffer at pH 7.8 and a microwave at full power
(900 W) for 15 min. All sections were allowed to cool
to room temperature before being rinsed in water. All
incubations and washes were performed using the
Shandon sequenza. A biotin block was performed on
the sections for 10 min using the Zymed avidin/biotin
blocking kit (Invitrogen Ltd) before incubating with
primary antibody (CD68 clone PG-M1 (Dako, Carpin-
teria, CA, USA) 1:100 dilution) in 10% (v/v) normal
swine serum in TBS buffer for 60 min. Negative control
sections were incubated in TBS buffer without primary
antibody. The positive control sections used were human
tonsil tissue. The sections were then washed in TBS
buffer before incubating in Link reagent (Dakocytomation
(yellow)) for 10 min. The sections were then rinsed again
in TBS buffer (pH 7.8), incubated with streptavidin
reagent from Dakocytomation (red) for 10 min, rinsed in
TBS buffer (pH 7.8) before incubating with CheMate
liquid 3,30-diaminobenzidine (DAB; TBS buffer, 1:50) for
approximately 10 min. Finally, sections were counter-
stained with Meyer’s haematoxylin for 45 s and processed
100% (v/v) ethanol and xylene. CD68 positive cells were
counted in triplicate by masked observers in three
identical ﬁelds of view per slide for each adipose depot.
11b-HSD immunohistochemistry Immunoperoxidase
studieswereperformed on OF sections using antisera raised in
sheep against human 11b-HSD1 (amino acid residues 18–33)
and 11b-HSD2 (amino acid residues 137–160 and 334–358;
The Binding Site, Birmingham, UK). Antibody dilutions
were in the ratio of 1:100 for 11b-HSD1 and 1:100 for 11b-
HSD2. Control sections included the omission of primary
antibody and use of antibody pre-treated with the immunis-
ing peptides. Secondary antibodies comprised donkey anti-
sheep peroxidase conjugate (1:100; Binding Site). Sections
were visualised with the peroxidase substrate DAB. Human
liver and kidney sections were used as positive control tissues
for 11b-HSD1 and 11b-HSD2 respectively.
Orbital preadipocyte isolation and primary cultures
Orbital (nZ12), SC (nZ34) and OM (nZ34) preadipocytes
were isolated using methodology previously reported (Bujalska
et al. 2002). The OF protocol was adapted to maximise yield
fromthesmallsamplesize.Brieﬂy,orbitaladiposetissuebiopsies
were washed in PBS containing 50 000 U/l penicillin and
50 000 mg/l streptomycin (Life Technologies, Inc.). The tissue
was minced with sterile scissors in a Class II culture hood and
digested with collagenase class I (2 mg/ml; Worthington
Biochemical Corp., Reading, UK) in 1! Hanks’ Balanced
Salt Solution (Gibco Invitrogen Corporation) for 45 min at
37 8C. Samples were centrifuged at 500 g for 1 min, and the
supernatantcontainingconnectivetissuedebris,collagenaseand
lipid was removed leaving a pellet containing preadipocytes.
ThecellularpelletwaswashedwithDulbecco’smodiﬁedEagle’s
medium DMEM/Nutrient Mixture F-12 (Gibco) containing
15% (v/v) foetal calf serum (Gibco) and seeded on 48-well
plates.Cellswereleftovernighttoattachandallunattachedcells
(including red blood cells) were washed the following day with
1! Hanks’ Balanced Salt Solution. Enzyme assays were
performed in duplicate when preadipocytes were conﬂuent at
approximately 10 days of culture (see below). The identity of
cells were conﬁrmed by differentiating preadipocytes from one
wellofthe48-wellplateintomaturelipidcontainingadipocytes
(O90% cultured cells) using chemically deﬁned media.
11b-HSD enzyme assays in cultured orbital preadipocytes
In conﬂuent OF preadipocytes, the culture medium was
replaced with serum-free medium 2 h before incubation.
Dehydrogenase activity (cortisol to cortisone conversion) was
assessedusing100 nMunlabelledcortisol(SigmaChemicalCo)
diluted in serum-free medium and tracer amounts (1.5n M )o f
[
3H]cortisol (speciﬁc activity 74.0C i / m m o l ;N E N ,B o s t o n ,
MA,USA)at37 8Cfor24 h.Conversionofcortisonetocortisol
(oxo-reductase) was analysed by incubating cells with 100 nM
cortisone and tracer amounts of [
3H]cortisone (50 000 c.p.m.)
synthesised in-house (Stewart et al. 1994). After 24-h
incubation, steroids were extracted from the medium with ten
volumes of dichloromethane, separated by thin-layer chroma-
tography with chloroform:ethanol (92:8) as a mobile phase and
thefractionalconversionofsteroidswascalculatedafterscanning
analysis using a Bioscan 2000 radioimaging detector (Bioscan,
Washington, DC, USA). Following enzyme assay, cell
monolayers were lysed in 1 ml water for subsequent protein
assays. Total protein in each well was determined using a
standard protein assay reagent (Bio-Rad),and enzyme activities
wereexpressedaspmol/hper mg.Allassayswerecarriedoutin
duplicate for each preadipocyte primary culture derived from
individual patient samples.
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Total RNA was extracted from whole OF (nZ8), SC (nZ8)
and OM (nZ7) tissue stored in RNAlater at K20 8C using a
single-step extraction method (Tri-Reagent; Sigma-Aldrich).
RNA integrity was assessed by electrophoresis on 1% (w/v)
agarose gels, and quantity was determined spectrophotome-
trically at OD260. One microgram of total RNA was reverse
transcribed in 50 ml total volume using TaqMan Reverse
Transcription Reagents (Applied Biosystems, Warrington,
Cheshire, UK) according to the manufacturer’s guidelines.
The reaction was terminated by heating the cDNA to 95 8C
for 5 min and stored at K20 8C until required.
Real-time reverse transcriptase-PCR
11b-HSD1, 11b-HSD2, H6PDH, GRa, FABP4, G3PDH
and CD68 mRNA levels were measured using real-time
PCR using an ABI 7500 system (Perkin-Elmer, Biosystems,
Warrington, UK). PCR was performed in 25 ml reactions on
96-well plates in reaction buffer containing TaqMan universal
PCR mastermix (Applied Biosystems), 3 mM Mn(Oac)2,
200 mM deoxy-NTPs, 1.25 U AmpliTaq Gold polymerase
(Perkin-Elmer), 1.25 U AmpErase UNG (Perkin-Elmer),
900 nmol primers, 100–200 nmol TaqMan probe and
25–50 ng cDNA. All reactions were multiplexed with
primers speciﬁc for 18S rRNA (provided as a pre-optimised
mix; Perkin-Elmer, Beaconsﬁeld, Bucks, UK) as an internal
reference and were carried out in duplicate. Data were
obtained as Ct values (the cycle number at which logarithmic
PCR plots cross a calculated threshold line) and used to
determine dCt values (dCtZCt of the target gene minus Ct
of the internal reference, 18S). All target gene probes were
labelled with the ﬂuorescent label 6-carboxyﬂuorescein, and
the housekeeping gene was labelled with the ﬂuorescent label
VIC. Reactions were as follows: 50 8C for 2 min, 95 8C for
10 min, and then 40 cycles of 95 8C for 15 s and 60 8C for
1 min. All expression data are presented as fold-change when
compared with OF using the equation 2
KDDCt (DDCt is the
difference between dCt values in SC or OM minus dCt in
OF). Sequences of oligonucleotide primers and probes were
as follows: (i) 11b-HSD1 antisense primer 50-AGGAAAGCT-
CATGGGAGGACTAG-30, sense primer 50-ATGGTGAA-
TATCATCATGAAAAAGATTC-30, probe 50-CATGCT-
CATTCTCAACCACATCACCAACA-30;( i i )G R a antisense
primer50-GCGATGGTCTCAGAAACCAAAC-30,sensepri-
mer 50-GAGATTACAGAGGAAGTTATCCTCTGC-30,
probe 50-TGCAGTGAAGGTTGCTGAGGCTCTGA-30;
(iii) H6PDH antisense primer 50-CAGGTGTCCTAGTGCA-
CATTGAC-30, sense primer 50-GTAGCCCACTCTCTC-
GTCCAA-30,p r o b e5 0-AAGGCACGCCCTCCCAGCG-30;
(iv) G3PDH antisense primer 50-CCATCAGTTCATCGG-
CAAGAT-30, sense primer 50-TCGTCTACCCCCTTAA-
TAAGAGATATG-30,p r o b e5 0-AGGGCCATCTGAAGGC
AAACGCC-30. Primers and probes for CD68 and FABP4
were from Expression Assays Applied Biosystems.
Ethics and statistical methods
The collection of human tissues for in vitro investigation was
approved by the local ethics committee. Informed consent
was obtained from all patient volunteers.
Statistical analysis was performed using the software
package SPSS for Windows Version 11.5.1 (SPSS, Inc.,
Chicago, IL, USA, 2002), Minitab Release 14.12 (Minitab
Ltd, Coventry, UK) and Prism for Windows Version 4.03c
(GraphPad Software, Inc., San Diego, CA, USA). Histo-
logical characterisation comparisons between the three fat
depots were made using a nested general linear model
regression analysis for replicated measuresof data(to minimise
loss of data by averaging individual readings), followed by
integrated pairwise comparisons. Data are presented as means
and 95% conﬁdence intervals. Enzyme assay data are
presented as means with standard errors of the separate
experiments. Real-time PCR analyses were performed with
dCt values to exclude potential bias due to averaging and
transforming data through the equation 2
KDDCt to give a
fold-change in gene expression. Statistical analyses were
performed using a non-parametric Mann–Whitney test for
non-normal data, or t-test/ANOVA for normally distributed
data. P values !0.05 were accepted as statistically signiﬁcant.
Results
Characterisation of whole tissue adipocyte morphology
Adipocyte diameter, perimeter and area (Fig. 1A–C respect-
ively) were identiﬁed as optimal parameters differentiating
adipocyte morphology from the different depots. Mean cell
diameter, perimeter, adipocyte area and feret length deﬁned
similar trends (OF!OM!SC; P!0.001) across the three
adipocyte depots. OF adipocytes were the smallest adipocyte
with mean cell diameter (50.7 mm, 95%CI 49.8–51.6),
shortestperimeter(149 mm,95%CI146.7–152.7)andsmallest
area (2470 mm
2, 95% CI 2382–2560). SC adipocytes were the
largestaccordingtoeachoftheseparameters.Radiusratio,cell
roundness and margination followed similar trends to each
other across the groups but these trends were not signiﬁcant
(OFOOM!SC; PZNS, data not shown), and cell count per
area of interest did not differentiate signiﬁcantly between
depots. Representative haematoxylin and eosin-stained
photomicrographs detailing histomorphometric character-
isation of the three adipose depots are shown in Fig. 1D–F.
Evaluation of CD68
C protein and mRNA expression in human
adipose depots
The largest resident CD68
C population was found in the OF
depot (median 7.6 (range 3.8–19.6) cell counts/unit area)
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counts/unit area, P!0.001) and OM (median 2.9 (range
0.6–5.2) cell counts/unit area, P!0.001; Fig. 2A). These
ﬁndings were endorsed by a similar trend in CD68 mRNA
expression for each depot (Fig. 2B (OFZ1; SCZ0.21;
P!0.05; OM 0.38!0.05 (fold-change when comparedwith
OF))). Representative photomicrographs showing CD68
C
macrophages in each whole adipose tissue depot (OF, SC and
OM) are shown in Fig. 2C–E.
Characterisation of 11b-HSD1 expression and activity in
orbital fat
Immunoreactivity was seen for 11b-HSD1 antibody in OF
sections (Fig. 3A) and around the central vein of human liver
(positive control; Fig. 3C). Minimal staining was detected
with 11b-HSD1 pre-adsorbed antibody (data not shown). No
staining was seen with 11b-HSD2 antibody in OF tissue
(Fig. 3B), whereas good staining was visualised in human
distal collecting duct epithelium in the kidney (positive
control, Fig. 3D).
Primary stromal cultures of OF preadipocytes, conﬁrmed
11b-HSD1 oxo-reductase activity (0.69G0.5p m o l / hp e r
mg (meanGS.E.M.)) when incubated for 24 h with 100 nM
cortisone and minimal dehydrogenase activity
(0.11G0.08 pmol/h per mg (meanGS.E.M.); P!0.05;
Fig. 4A–C). Oxo-reductase activity was greatest in OM
preadipocytes when compared with SC (43.7G5.2v s
17.6G3.6 pmol/mg per h (meanGS.E.M.) P!0.001) and
OF preadipocytes (OF versus SC; P!0.01; OF versus OM;
P!0.001; Fig. 4D).
Comparison of 11b-HSD1 and glucocorticoid-related target gene
expression in whole adipose tissue depots
11b-HSD1 mRNAwas expressed within OF tissue, although
quantitative real-time PCR analyses across the three whole
adipose tissue depots revealed lowest levels of expression in
OF when compared with SC and OM adipose depots
(OFZ1; SCZ8.1, P!0.001; OMZ10!0.001 (fold-
change when compared with OF); Fig. 5A). Nevertheless,
these data reﬂect our 11b-HSD1 oxo-reductase activity data
detailed earlier.
Whole tissue analyses indicated the highest expression of
GRa mRNA in OF when compared with SC and OM
adipose tissue (Fig. 5A). Conversely, H6PDH mRNA
(NADPH provider for 11b-HSD1 oxo-reductase activity;
Fig. 5A) and markers of late adipocyte differentiation (FABP4,
G3PDH) were signiﬁcantly lower in OF (Fig. 5B).
Discussion
In this paper, we have described a novel reproducible
automated method for the histomorphometric analysis of
adipose tissue from differing human depots. This has been
performed in the context of gene expression proﬁling and has
identiﬁed important depot speciﬁc differences in adipocyte
biology and GC metabolism.
In comparison with OM and SC depots, orbital adipocytes
were signiﬁcantly smaller, expressed lower levels of adipocyte
differentiation markers (FABP4 and G3PDH), but revealed a
higher CD68
C cellular inﬁltrate. Examination of the key
players of the GC metabolic pathways, conﬁrmed that all
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Figure1 Adipocytemorphology.Diameteroftheindividualadipocyte(A),perimetercelldiameter(B)andarea(C),wereidentiﬁed asoptimal
characteristics deﬁning adipocyte morphology. Smallest adipocytes were found in the orbital fat (OF) depot (D), while SC adipocytes
were the largest cell (E). Omental (OM) adipocytes were statistically larger than OF but smaller than SC (F) (OF, nZ17; SC, nZ8; OM, nZ8;
results are expressed as mean and 95% conﬁdence intervals; *P!0.001).
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published studies (Heufelder et al. 1992, Burnstine et al. 1998,
Muhlberg et al. 2000, Boullu-Ciocca et al. 2003), but
expression in the OF depot was signiﬁcantly higher. In
addition, our data has deﬁned 11b-HSD1 oxo-reductase
activity and mRNA expression in OF together with its
regulatory enzyme, H6PDH, although these were at a lower
level than that seen in SC and OM tissues.
These observations highlight the importance of adipose
tissue, depot-speciﬁc analyses. Adipose tissue is regarded as an
‘endocrine organ’ and depot speciﬁcity of gene expression
between SC and OM depots is well described (Montague
et al. 1997). Furthermore, these changes are functionally
important with differing propensities for adipocyte differen-
tiation, proliferation, apoptosis and lipid metabolism between
these depots (Vikman et al. 1995, Niesler et al. 1998). Our
data show that orbital adipose tissue is clearly distinct from
both SC and OM depots. The fundamental explanation for
these differences lies, in addition to genetic and environ-
mental factors, in the embryological origins of adipose
connective tissue. Whereas SC and OM ‘peripheral’ adipose
depots and ﬁbroblasts are derived from mesoderm, orbital
ﬁbroblasts originate from neuroectoderm (Smith 2004).
Studies have shown that orbital and peripheral ﬁbroblasts
have both distinguishing morphological phenotypic features
(Smith et al. 1995), but also at a molecular level, orbital
ﬁbroblasts have distinct deﬁning characteristics, including
expression of surface receptors, cellular proteins, responses to
cytokines and the ability to secrete and remodel matrix
proteins (Prabhakar et al. 2003, Ajjan & Weetman 2004,
Smith 2004). As orbital ﬁbroblasts are neural crest in origin,
they possess considerable plasticity – under appropriate in vitro
conditions, almost 50% may be differentiated into lipid
containing adipocytes (Smith et al. 2002). Hence, it has been
proposed that the unique nature of the orbital molecular
environment accounts for its underlying susceptibility to
autoimmune diseases (Kaminski et al. 2003).
The impact of the macrophage inﬁltrate in orbital adipose
tissue may also be important particularly as cytokines have
potent effects upon adipocyte biology. Recent studies have
shown that chronic inﬂammation activates adipose tissue in
simple obesity deﬁned by an increased accumulation of
CD68
C macrophages, increased adipocyte size and increased
TNFa in patients with high BMIs (Weisberg et al. 2003,
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Figure 2 Immunohistochemistry using human anti-CD68 for macrophages conﬁrmed a large resident population in the OF depot when
compared with SC and OM (A). Results are expressed as median and full range of counts. These ﬁndings were endorsed by real-time RT-PCR
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Figure 4 Primary cultures of OF preadipocytes conﬁrmed 11b-HSD1 oxo-reductase activity and
minimal dehydrogenase activity when incubated for 24 h with 100 nM cortisone and cortisol
respectively (nZ12) (A). Representative radiochromatograph traces are shown for dehydrogenase (B)
and oxo-reductase (C) activity. (D) Oxo-reductase activity was greatest in OM preadipocytes followed
by SC and OF adipocytes (*P!0.05;
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Pietila ¨inen et al. 2006). There is considerable heterogeneity
in monocyte-derived lineages (e.g. macrophages) and the
different monocyte subsets reﬂect the developmental stages
with distinct physiological roles, such as recruitment into
inﬂammatory lesions or entry to normal tissues (Gordon &
Taylor 2005). It is thought that with the expansion of adipose
tissue during weight gain, induction of a range of signalling
pathways activates the adipose vascular fraction allowing
monocytes to extravasate through the endothelial cell layer
into the adipose tissue where they differentiate into
macrophages localising predominantly around dead
adipocytes (Neels & Olefsky 2006). Crosstalk between
adipocytes, macrophages and endothelial cells aggravates
the inﬂammatory state, resulting in increased secretion of
pro-inﬂammatory cytokines/chemokines, adipokines and
angiogenic factors. Furthermore, the interaction of cytokines
and GC metabolism may be an additional contributing factor.
TNFa, IL-6 and IL-1b are potent inducers of 11b-HSD1
expression and activity in adipose tissue (Tomlinson et al.
2001). Macrophage-derived cytokine production in vivo may
serve to augment cortisol generation through induction of
11b-HSD1. TNFa speciﬁcally, in addition to modulating
11b-HSD1 activity, inhibits adipocyte differentiation,
proliferation and promotes apoptosis and de-differentiation
(Petruschke & Hauner 1993, Prins et al. 1997). This process
may be of considerable relevance to the orbital fat
microenvironment. The orbital fat samples analysed in this
study were all from healthy controls undergoing elective
orbital or lid surgery for non-inﬂammatory disease states, and
despite this, normal OF harboured a large CD68
C population
and adipocytes were less differentiated when compared with
SC and OM. These data reﬂect an orbital molecular
environment that has an increased potential and plasticity
that is vital to combat inﬂammatory, immune-mediated or
infective insult.
The role of GCs in the regulation of adipocyte biology is
exempliﬁed by patients with Cushing’s syndrome who
develop ﬂorid, but reversible central obesity. GCs are essential
for adipocyte differentiation (Hauner et al. 1987), inhibit
omental preadipocyte proliferation (Tomlinson et al. 2002),
but interestingly, promote proliferation in the SC depot
(Bader et al. 2002). 11b-HSD1 overexpression in adipose
tissues in rodent models induces obesity and the metabolic
syndrome (Masuzaki et al. 2001, 2003)a n ds e l e c t i v e
11b-HSD1 inhibitors have been suggested as a novel
therapeutic strategy (Alberts et al. 2002, 2003, Hermanows-
ki-Vosatka et al. 2005). The identiﬁcation of 11b-HSD1 in
human orbital adipose tissue is an important ﬁnding and raises
the possibility that the local generation of GC within this
depot may be functionally important. Although levels were
lower than those observed in SC and OM depots, the
increased expression of GRa is likely to compensate for this.
Low levels of oxo-reductase activity have been documented
in other tissue depots, notably bone (Cooper et al. 2002). In
this tissue, low basal levels are believed to be physiologically
signiﬁcant, as induction of oxo-reduction activity increasing
GC bioavailability is seen when osteoblasts are challenged
with pro-inﬂammatory cytokines (Cooper et al. 2001).
Critically, unlike the SC and OM depots, the orbital fat
depot lies within a conﬁned space surrounding tissues
susceptible to compression. Therefore, rapid expansion,
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Figure 5 Whole adipose tissue real time RT-PCR analyses showed signiﬁcantly higher expression of 11b-HSD1 and H6PDH mRNA in SC
and OM when compared with OF. Conversely, highest expression of GRa mRNA in OF when compared with SC and OM is seen (A).
FABP4, G3PDH mRNA expression (markers of late adipocyte differentiation) were signiﬁcantly lower in OF (B). Results are expressed as
fold-change when compared with orbital fat; dCt are shown in tables below (*P!0.05;
†P!0.001).
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Journal of Endocrinology (2007) 192, 279–288 www.endocrinology-journals.orgperhaps as a consequence of enhanced GC autocrine
generation through 11b-HSD1, may have important sight-
threatening clinical implications. The possibility of dysregula-
tion of 11b-HSD1 in disease states (particularly those with
underlying inﬂammatory and immune-mediated aetiologies)
requires further investigation, and a detailed characterisation
of expression and functional importance in these conditions is
now warranted.
To conclude, orbital adipose tissue is a biologically distinct
adipose tissue depot. Adipocytes are smaller and less
differentiated than SC and OM. The identiﬁcation of 11b-
HSD1 and H6PDH expression and activity within the depot,
together with an abundant GRa and a large CD68
C
population deﬁne a microenvironment that has the potential
to respond to sight-threatening orbital inﬂammatory disease.
Our data raise the exciting possibility that the autocrine
generation of cortisol may be functionally important in
regulating orbital adipocyte biology and that this may be
amenable to therapeutic modulation.
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